Searched for
BENIGN PROSTATIC HYPERPLASIA
Stocks in news: Indian Hotels, RailTel, Dr Lal PathLabs, Torrent Power, LupinRailTel received an order worth Rs 352 cr from BMC for supply, operations and maintenance of the health department of the corporation.- SC refuses to entertain Asaram's plea for suspension of sentence in rape case on health groundsA bench of Justice Sanjiv Khanna and Justice Dipankar Datta asked senior advocate Mukul Rohatgi to approach the Rajasthan High Court for re...
- Stocks in the news: Uniparts, Airtel, NTPC, Vodafone Idea, Marico and GlenmarkUniparts India will be listed at bourses on Monday. Its Rs 835.6 crore IPO was open was open between November 30 and December 2, sold in th...
- Health conditions men should keep track ofHeart disease, stroke, diabetes, cancer and depression are the top male killers. However, men also face male-specific issues such as prosta...
- Torrent Pharma acquires 4 brands from Dr.Reddy’sStyptovit-E, is a gynaecology product with an estimated market size of Rs. 500 crores as per AIOCD data, is expected to strengthen Torrent’...
- Alembic gets USFDA nod for Silodosin capsulesAlembic Pharmaceuticals on Tuesday said it has received final approval from the US health regulator for its generic Silodosin capsules used...
- Zydus Cadila gets USFDA nod for prostate condition treatment drugThe drug is used to treat symptoms of Benign Prostatic Hyperplasia (BPH) -- also called prostate gland enlargement.
- Sun Pharma recalls two lots of diabetes drug due to microbial contaminationAccording to US FDA, a Class II recall occurs in a situation where use of or exposure to the product may lead to temporary or medically rev...
- Zydus Cadila gets USFDA nod to market Doxazosin tabletsThe company has also received the tentative approval from the USFDA to market Lurasidone Hydrochloride Tablets in the strengths of 20 mg, 4...
- Zydus Cadila gets USFDA nod to market Doxazosin tabletsThe company has also received the tentative approval from the USFDA to market Lurasidone Hydrochloride Tablets in the strengths of 20 mg, 4...
- Pharma sector to soon showcase new drugs: Harsh VardhanThe Minister announced that CDRI is carrying out IND studies on lead molecules for fracture-healing, cancers, thrombosis, malaria and hyper...
- Sun Pharma gets USFDA nod to market generic Uroxatral tabletsThe company's Alfuzosin Hydrochloride 10-mg tablets are therapeutically equivalent to drug-maker Sanofi-Aventis' Uroxatal extended release ...
- Unichem gets EU nod for drug to treat enlarged prostateUnichem Laboratories on Thursday said it has received a certificate of suitability for its generic drug for treatment of enlarged prostate ...
- Sun Pharma gets USFDA nod for Flomax's generic versionSun Pharmaceutical Industries today said that it has received the US health regulator's nod to market a generic version of Flomax tamsulosi...
- Ranbaxy signs agreement with German insurance firmDrug major Ranbaxy Laboratories Ltd on Wednesday said its wholly-owned European subsidiary, Basics Gmbh has entered into an agreement with ...
- Ranbaxy receives nod for Tamsulosin Hydrochloride capsules in CanadaRanbaxy Laboratories has received approval to manufacture and market Tamsulosin Hydrochloride capsules in 0.4 mg strength from Health Canad...
- Ranbaxy, Astellas end patent rowRanbaxy Laboratories has reached an out-of-court settlement with Japanese company Astellas and Boehringer Ingelheim to sell Flomax, a drug ...
- Ranbaxy gets tentative US nod for TamsulosinRanbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories, has received tentative approval from the U.S. Food a...
Load More
